Australia’s coronavirus vaccine rollout has been beset by challenges, and one of the big ones is the fact that we have limited supply of the vaccine that is recommended for the majority of the population: Pfizer.
This was frustrating a month or so ago but has now become an urgent issue with the virus spreading in Australia’s two biggest cities.
Supplies of Pfizer are due to ramp up in the coming months, but people are at risk of infection now. So how do you best manage a finite resource when you’re dealing with an outbreak?
Some countries overseas have experience which we here could learn from if we’re open to new ideas.
Guest: Professor Nancy Baxter
Head of the University of Melbourne’s School of Population and Global Health